While poor diet and lack of exercise are thought to be the leading causes of diabetes, exposure to polluted air early in life can also lead to the disease….
Read More »New Product: Amturnide
Amturnide (aliskiren, amlodipine and hydrochlorothiazide) from Novartis is a medication in tablet form for the treatment of high blood pressure. Amturnide combines the direct renin inhibitor Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).
Read More »A Year of Diabetes Research 2010
Prevention, therapy and complications are the keystones for diabetes research. It would be impossible to cover all of the developments in just one feature. So here is a brief summary of some of the best for 2010.
Read More »Whole-Fat Milk and Cheese Can Lower Diabetes Risk
The incidence of Type 2 diabetes declined significantly as levels of a fatty acid found in whole-fat dairy products increased….
Read More »What Are Your Waiting for? Start Metformin Early
For newly diagnosed Type 2 diabetes patients, waiting until lifestyle measures fail before starting metformin may jeopardize the long-term efficacy of the drug….
Read More »Preventing Diabetes: All We Have to Do Is Ask!
Why are we missing chances to prevent diabetes? Physicians in the United States are rarely diagnosing prediabetes….
Read More »Researchers Turn White Fat to Energy-Burning Brown Fat
Certain cells in white fat can be changed into energy-burning brown fat, according to an animal study that could lead to new treatments for obesity….
Read More »Lilly Applies for Expanded Use of BYETTA® with Basal Insulin
A supplemental New Drug Application (sNDA) has been submitted to the FDA for the expanded use of BYETTA® (exenatide) injection as an add-on therapy to basal insulin, with or without metformin and/or a thiazolidinedione (TZD) in conjunction with diet and exercise for adults with Type 2 diabetes….
Read More »Disease-Management Programs Shown to Improve Diabetes Care
Disease-management programs, which may include patient education, psychological intervention, dietary education, self-monitoring, and telemedicine, can improve diabetes care…..
Read More »Low HDL, in Statin-Treated Patients, Associated with Increased CVD Risk
Low levels of HDL-cholesterol levels, despite treatment with statin therapy for elevated LDL-cholesterol levels, remains a significant risk factor for cardiovascular events….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.